The Concinnity Company, Developer of Smarter Software for Clinical Trial Oversight, Partners with Cancer Research And Biostatistics (CRAB) to Provide the Ultimate Data Monitoring Committee Experience
News provided by
Share this article
Share this article
NASHVILLE, Tenn., May 20, 2021 /PRNewswire/ With the onset of the pandemic and a new lens on the critical importance of clinical trial data oversight, CRAB decided to expand its services for Data Monitoring Committees (DMCs or DSMBs). To ensure the success of this new line of service, CRAB worked to identify the best software solution for managing these important clinical trial oversight committees. They soon founded The Concinnity Company and its Cloud Concinnity